"10.1371_journal.pone.0046546","none","2012-10-03T00:00:00Z","Xiaomin Han; Jing Zhang; Liang Guo; Rihui Cao; Yongzhen Li; Ni Li; Qin Ma; Jialin Wu; Yanchang Wang; Shuyi Si","Institute of Medicinal Biotechnology, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; Xinjiang Huashidan Pharmaceutical Co., Urumqi, People’s Republic of China; Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida, United States of America","Conceived and designed the experiments: XMH JZ YCW SYS. Performed the experiments: XMH JZ YZL NL. Analyzed the data: XMH JZ YZL YCW SYS. Contributed reagents/materials/analysis tools: XMH JZ YZL NL LG RHC QM JLW YCW SYS. Wrote the paper: XMH JZ YZL YCW SYS. Contribution type: XMH JZ.","Liang Guo, Rihui Cao, Qin Ma and Jialin Wu are employed by the Xinjiang Huashidan Pharmaceutical Co. All the beta-carboline derivatives tested in this study were provided by Xinjiang Huashidan Pharmaceutical Co. Ltd. (The Patent information of Xinjiang Huashidan Pharmaceutical Co. Ltd as following: title: Beta-carboline derivatives and their application, Patent number: 201010108531.4 (China application number). There are no other patents, products in development or other marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","10","Xiaomin Han","XH",10,TRUE,4,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
